GC Rieber VivoMega will launch an EPA and DHA Algae oil, VivioMega EPA+DHA Algae 2050 TGP, for the North American market at Expo West in Anaheim, California. Following a launch in the U.S., which has the largest omega-3 supplements market, other regional launches will follow.
 
“Adding an EPA and DHA combination to our algae portfolio is a big win for us, our customers, partners, and the end consumer,” said Ståle Søfting, sales and marketing director. “These EPA and DHA offerings provide a non-GMO, solvent-free, sustainable, and alternative source for these essential fatty acids. Additionally, as the supply and increased costs of fish oil remain top of mind for suppliers and manufacturers, algae concentrates offer a great alternative to support the demands of consumers wanting omega-3s.”
 
Many algae products in the market are refined, or are concentrates available only in the ethyl ester form. Vivomega’s algae concentrate is 90% triglycerides, which, according to VivoMega, offers increased bioavailability for improved absorption in the body. It has a 73% long-chain omega-3 fatty acids content and is vegan certified.
 
The GC Rieber Group has spearheaded processing and purification of omega-3 concentrates for sensory profile and purity. Its proprietary processing technology, SuperLight, is designed and developed exclusively for algae oils. Its process utilizes high-end technologies, allowing for gentle and non-invasive processing with strong oxidation protection, resulting in improved quality parameters and resource utilization with little to no waste.
 
GC Rieber VivoMega’s products are also SEDEX-certified and are aligned with the EU Green Deal initiatives and the UN Global Compact guidelines.